Skip to main content
Log In
Create Account
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Light
Dark
Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN
Watchlist
Compare
33.50
+1.35 (4.20%)
May 9, 2025, 5:03 PM CET
Overview
Financials
Statistics
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
Metrics
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Fiscal Year
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
Period Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
Novel Small Molecule Therapies
46.86M
Log In
Log In
Log In
Log In
Novel Small Molecule Therapies Growth
20.32%
Log In
Log In
Log In
Log In
Service
-
Log In
Log In
Log In
Log In
Service Growth
-
Log In
Log In
Log In
Log In
Bioinformatics
-
Log In
Log In
Log In
Log In
Bioinformatics Growth
-
Log In
Log In
Log In
Log In
Exclusion Income between Segments
-
Log In
Log In
Log In
Log In
Revenue by Geography
Fiscal year is January - December.
Download
Fiscal Year
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
Period Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
European Union Countries
41.66M
Log In
Log In
Log In
Log In
European Union Countries Growth
69.25%
Log In
Log In
Log In
Log In
Other Countries
5.16M
Log In
Log In
Log In
Log In
Other Countries Growth
-63.73%
Log In
Log In
Log In
Log In
Poland
38.00K
Log In
Log In
Log In
Log In
Poland Growth
-64.15%
Log In
Log In
Log In
Log In
United States
-
Log In
Log In
Log In
Log In